Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioTime, a developer of regenerative medicine, reported total revenues of $755,553 for the second quarter ended 30 June 2011, an increase of 11%, compared to $680,278 for the same period in 2010.
Subscribe to our email newsletter
The company has posted a net loss of $5m for the second quarter of 2011, compared to $2.35m for the same period in 2010.
The company’s loss from operations were $4.98m, compared to 2.32m for the same period prior year.
For the six months ended 30 June 2011, the company reported total revenues of $1.58m, compared to $1.45m for the same period in 2010.
BioTime has reported net loss of $8.94m for the six months ended 30 June 2011, compared to $3.67m for the same period in 2010.
For the six months ended 30 June 2011, the company’s loss form operations were $9.01m, compared to $3.64m for the same period prior year.